Piper Sandler launched the coverage of a raft of cancer-focused biotechs with bullish views on Monday while issuing a Neutral recommendation on Summit Therapeutics (NASDAQ:SMMT), citing an unfavorable ...
GitLab Inc. (NASDAQ:GTLB) is one of the AI Stocks Analysts are Tracking Closely. On November 10, Piper Sandler analyst Rob Owens reiterated an Overweight rating on the stock with a $70.00 price target ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback